Biotech Startups
9,920 companies tagged Biotech, with their investors and founders.
SiSaf is an RNA delivery and therapeutics company that uses its proprietary bioabsorbable silicon-based Bio-Courier technology to deliver nucleic acids, avoiding the ultra-cold supply chain of conventional lipid nanoparticles. It is developing a pipeline of RNA therapeutics targeting pancreatic cancer, metastatic cancer, and the rare skeletal disease osteopetrosis ADO2.
2 investors
SiteRx works to make clinical research more accessible by improving transparency and diversity in clinical trials, connecting patients with research opportunities for their medical conditions. The company focuses on bringing treatments to market more efficiently, with a stated interest in Alzheimer's disease research.
2 investors
Sixfold develops RNA delivery technology for the biotech industry. The company was founded by an oncologist and plant scientist and focuses on advancing RNA-based therapeutic approaches through proprietary delivery methods.
2 investors
Slate Bio develops regulatory T cell (Treg) therapies for treating autoimmune diseases. The company focuses on advancing immunology treatments for patients with autoimmune conditions.
2 investors
Slate Medicines is a clinical-stage biotechnology company. The page profiles an executive but provides limited detail on the company's specific therapeutic focus.
2 investors
Sleuth provides evidence-backed answers for biopharma decision-making, built on a knowledge graph that maps over a billion relationships across biology, clinical evidence, competitive dynamics, and deal history. It ingests data from hundreds of structured and unstructured sources—including sell-side research, patents, SEC filings, and Chinese biotech pipelines—with full traceability from each output back to its source.
2 investors
Sofinnova Partners is a venture capital and private investment firm that invests across multiple strategies including biotech, digital health, industrial biotechnology, and capital markets. The firm manages multiple specialized investment strategies focused on life sciences and healthcare innovation.
2 investors
Solabia is a producer of raw materials including ingredients, active ingredients, culture media, and diagnostic kits for the cosmetics, pharmaceutical, nutraceutical, and biotechnology industries. The group serves manufacturers in these sectors with a focus on innovation, sustainability, and responsible growth.
2 investors
Solar Foods produces Solein, a sustainable protein ingredient created through gas fermentation technology that converts CO2 and renewable electricity into edible protein. The company targets food brands and the health & performance nutrition market seeking alternatives to conventional animal and plant proteins.
2 investors
2 investors
Solaxa is a biotech company developing pharmacological and cell-based treatments for peripheral nerve injury and spinal cord injury, drawing on regenerative medicine and nerve technologies. It focuses on drug and drug-device combination products in the field of neurology.
2 investors
2 investors
Soley Therapeutics develops proprietary imaging, AI, and automation technology to analyze cellular responses to stress and drug exposure, enabling the discovery of novel medicines and therapeutic mechanisms.
2 investors
Solu provides a cloud-based genomic surveillance platform that analyzes microbial genomes in real-time without requiring coding or configuration. The platform serves public health institutions, research labs, and medical centers performing pathogen sequencing, outbreak detection, and antimicrobial resistance monitoring.
2 investors
Solu Therapeutics is a clinical-stage biotech developing a class of antibody therapeutics that link bifunctional small molecules to proprietary effector antibodies (its CyTAC and TicTAC platforms) to reach cell surface targets like GPCRs and ion channels. Its pipeline targets oncology, immunology and inflammation, and pain, with a lead program in Phase 1 trials for chronic myelomonocytic leukemia.
2 investors
SOLVE Chemistry runs an automated lab with high-throughput data collection and machine learning to generate FAIR kinetic data, quantitative yield insights, and micro-kinetic models for organic synthesis. It serves pharmaceutical and agrochemical companies looking to speed up process development and scale-up of chemical reactions.
2 investors
SomaLogic develops proteomics tools that help researchers measure protein function and study human biology across a range of scientific applications. The company is now part of Illumina, combining proteomics with genomics for a multiomics approach.
2 investors
Sonrai Analytics provides scientific data analysis services for biomedical research programs, combining bioinformatics, data science, and translational expertise to convert complex datasets into actionable clinical evidence. The company serves research teams and clinical programs globally.
2 investors
Spark Biomedical develops wearable neurostimulation devices for bioelectronic medicine applications, primarily targeting mental health, women's health, hemostasis, and pediatrics. The company's FDA-cleared product treats opioid withdrawal and is conducting multiple clinical trials to expand into additional therapeutic areas.
2 investors
Spark Therapeutics, now part of the Roche Group, focuses on delivering therapies to improve patient outcomes and create healthier communities. The company operates within the pharmaceutical and healthcare sector.
2 investors
2 investors
Spineology develops minimally invasive spine surgery implants, including its flagship OptiMesh interbody fusion technology that delivers a bone graft-containing implant through a small surgical portal. The company serves spine surgeons and their patients in the orthopedic medical device market.
2 investors
Spirea develops a multivalent ADC linker technology called ELIVATE that expands the range of usable payloads for antibody-drug conjugates, aiming to enable next-generation ADCs for oncology, inflammation, and autoimmune diseases. The company develops proprietary linker-payloads and offers ADC design and conjugation expertise for partnering with pharmaceutical and biotech companies.
2 investors
Spiro Medical is a clinical-stage medical device company developing neuromodulation therapies for severe, uncontrolled asthma and other respiratory conditions. The company targets the neurological mechanisms underlying respiratory disease to provide treatment options for patients who have not benefited from conventional therapies.
2 investors